Related Experiment Videos
An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles
Oded Rabin1, J Manuel Perez, Jan Grimm
1Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, USA.
Nature Materials
|January 31, 2006
Summary
Researchers developed novel bismuth sulfide (Bi(2)S(3)) nanoparticles for computed tomography (CT) imaging. These biocompatible nanoparticles offer superior X-ray absorption and longer circulation times, enhancing in vivo imaging capabilities.
Area of Science:
- Biomedical Imaging
- Nanotechnology
- Materials Science
Background:
- Nanomaterials are crucial for molecular probes in in vivo imaging.
- Current computed tomography (CT) contrast agents (iodinated molecules) have limitations in distribution and pharmacokinetics.
- Nanomaterials have not been explored for CT imaging.
Purpose of the Study:
- To develop and evaluate polymer-coated bismuth sulfide (Bi(2)S(3)) nanoparticles as an injectable CT imaging agent.
- To assess the performance of Bi(2)S(3) nanoparticles compared to traditional iodinated contrast agents.
Main Methods:
- Preparation of polymer-coated Bi(2)S(3) nanoparticles.
- Evaluation of nanoparticle stability, X-ray absorption, and in vivo pharmacokinetics.
- In vivo imaging studies in mice to assess vasculature, liver, and lymph node visualization.
Main Results:
- Bi(2)S(3) nanoparticles exhibit excellent stability and high X-ray absorption (5x better than iodine).
- Demonstrated very long in vivo circulation times (>2 hours).
- Achieved comparable or better efficacy/safety profiles than iodinated agents.
Conclusions:
- Polymer-coated Bi(2)S(3) nanoparticles are a promising injectable CT imaging agent.
- These nanoparticles enhance in vivo imaging of various organs and vasculature.
- Expected to advance molecular imaging for pathological conditions.